261 related articles for article (PubMed ID: 37446800)
1. Natural Products and Biological Activity from Actinomycetes Associated with Marine Algae.
Xiong Z; Wang R; Xia T; Zhang S; Ma S; Guo Z
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446800
[TBL] [Abstract][Full Text] [Related]
2. Culturable rare Actinomycetes: diversity, isolation and marine natural product discovery.
Subramani R; Aalbersberg W
Appl Microbiol Biotechnol; 2013 Nov; 97(21):9291-321. PubMed ID: 24057404
[TBL] [Abstract][Full Text] [Related]
3. Bioactive Metabolites from Terrestrial and Marine Actinomycetes.
Ngamcharungchit C; Chaimusik N; Panbangred W; Euanorasetr J; Intra B
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570885
[TBL] [Abstract][Full Text] [Related]
4. Natural Products from Actinomycetes Associated with Marine Organisms.
Chen J; Xu L; Zhou Y; Han B
Mar Drugs; 2021 Nov; 19(11):. PubMed ID: 34822500
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances of Actinomycetes.
Kim ES
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33494267
[TBL] [Abstract][Full Text] [Related]
6. Marine actinomycetes: an ongoing source of novel bioactive metabolites.
Subramani R; Aalbersberg W
Microbiol Res; 2012 Dec; 167(10):571-80. PubMed ID: 22796410
[TBL] [Abstract][Full Text] [Related]
7. Marine Actinomycetes-derived Natural Products.
Yang C; Qian R; Xu Y; Yi J; Gu Y; Liu X; Yu H; Jiao B; Lu X; Zhang W
Curr Top Med Chem; 2019; 19(31):2868-2918. PubMed ID: 31724505
[TBL] [Abstract][Full Text] [Related]
8. Ecological Strategies Behind the Selection of Cultivable Actinomycete Strains from the Yucatan Peninsula for the Discovery of Secondary Metabolites with Antibiotic Activity.
Parera-Valadez Y; Yam-Puc A; López-Aguiar LK; Borges-Argáez R; Figueroa-Saldivar MA; Cáceres-Farfán M; Márquez-Velázquez NA; Prieto-Davó A
Microb Ecol; 2019 May; 77(4):839-851. PubMed ID: 30761424
[TBL] [Abstract][Full Text] [Related]
9. Development of a drug discovery approach from microbes with a special focus on isolation sources and taxonomy.
Igarashi Y
J Antibiot (Tokyo); 2023 Jul; 76(7):365-383. PubMed ID: 37188757
[TBL] [Abstract][Full Text] [Related]
10. Marine actinobacteria: an important source of bioactive natural products.
Manivasagan P; Kang KH; Sivakumar K; Li-Chan EC; Oh HM; Kim SK
Environ Toxicol Pharmacol; 2014 Jul; 38(1):172-88. PubMed ID: 24959957
[TBL] [Abstract][Full Text] [Related]
11. Continuing hunt for endophytic actinomycetes as a source of novel biologically active metabolites.
Masand M; Jose PA; Menghani E; Jebakumar SR
World J Microbiol Biotechnol; 2015 Dec; 31(12):1863-75. PubMed ID: 26410426
[TBL] [Abstract][Full Text] [Related]
12. Secondary metabolites from mangrove-associated fungi: source, chemistry and bioactivities.
Chen S; Cai R; Liu Z; Cui H; She Z
Nat Prod Rep; 2022 Mar; 39(3):560-595. PubMed ID: 34623363
[TBL] [Abstract][Full Text] [Related]
13. A Genomic Survey of the Natural Product Biosynthetic Potential of Actinomycetes Isolated from New Zealand Lichens.
Hou P; Nowak VV; Taylor CJ; Calcott MJ; Knight A; Owen JG
mSystems; 2023 Apr; 8(2):e0103022. PubMed ID: 36749048
[TBL] [Abstract][Full Text] [Related]
14. [Advances in the biosynthesis of cyclodipeptide type natural products derived from actinomycetes].
Huang Y; Li J; Chen S; Liu W; Wu M; Zhu D; Xie Y
Sheng Wu Gong Cheng Xue Bao; 2023 Nov; 39(11):4497-4516. PubMed ID: 38013180
[TBL] [Abstract][Full Text] [Related]
15. Intimate relationships among actinomycetes and mycolic acid-containing bacteria.
Kato M; Asamizu S; Onaka H
Sci Rep; 2022 May; 12(1):7222. PubMed ID: 35508597
[TBL] [Abstract][Full Text] [Related]
16. Endophytic actinomycetes: promising source of novel bioactive compounds.
Matsumoto A; Takahashi Y
J Antibiot (Tokyo); 2017 May; 70(5):514-519. PubMed ID: 28270688
[TBL] [Abstract][Full Text] [Related]
17. Marine actinomycetes as an emerging resource for the drug development pipelines.
Zotchev SB
J Biotechnol; 2012 Apr; 158(4):168-75. PubMed ID: 21683100
[TBL] [Abstract][Full Text] [Related]
18. Bacteria From Marine Sponges: A Source of New Drugs.
Bibi F; Faheem M; Azhar EI; Yasir M; Alvi SA; Kamal MA; Ullah I; Naseer MI
Curr Drug Metab; 2017; 18(1):11-15. PubMed ID: 27739371
[TBL] [Abstract][Full Text] [Related]
19. Applications and Restrictions of Integrated Genomic and Metabolomic Screening: An Accelerator for Drug Discovery from Actinomycetes?
Krause J
Molecules; 2021 Sep; 26(18):. PubMed ID: 34576921
[TBL] [Abstract][Full Text] [Related]
20. Marine actinomycete diversity and natural product discovery.
Jensen PR; Mincer TJ; Williams PG; Fenical W
Antonie Van Leeuwenhoek; 2005 Jan; 87(1):43-8. PubMed ID: 15726290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
